|
US3639385A
(en)
|
1968-07-26 |
1972-02-01 |
Eastman Kodak Co |
Heterocyclic monoazo compounds from n n-diaralkyl anilines and polyester textile materials dyed therewith
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US4181803A
(en)
|
1973-12-14 |
1980-01-01 |
Eisai Co., Ltd. |
Propiophenone derivatives and preparation thereof
|
|
US4326525A
(en)
|
1980-10-14 |
1982-04-27 |
Alza Corporation |
Osmotic device that improves delivery properties of agent in situ
|
|
ATE25078T1
(de)
|
1982-10-27 |
1987-02-15 |
Degussa |
2-amino-3-acylamino-6-benzylamino-pyridinderivate mit anti-epileptischer wirkung.
|
|
DE3337593A1
(de)
|
1982-10-27 |
1984-05-03 |
Degussa Ag, 6000 Frankfurt |
2-amino-3-acylamino-6-benzylamino-pyridin-derivate mit antiepileptischer wirkung
|
|
DE3665538D1
(en)
|
1985-01-23 |
1989-10-19 |
Asta Pharma Ag |
Synergistic combination of flupirtin and non-steroidal anti-phlogistics
|
|
EP0193056B1
(de)
|
1985-02-23 |
1989-06-07 |
ASTA Pharma Aktiengesellschaft |
Kombination von Flupirtin und anticholinergisch wirkenden Spasmolytika
|
|
DE3604575A1
(de)
|
1985-02-23 |
1986-08-28 |
Degussa Ag, 6000 Frankfurt |
Kombination von flupirtin und anticholinergisch wirkenden spasmolytika
|
|
JP2583067B2
(ja)
|
1987-08-04 |
1997-02-19 |
住友化学工業株式会社 |
モノアゾ化合物およびそれを用いて疎水性繊維材料を染色または捺染する方法
|
|
GB8800199D0
(en)
|
1988-01-06 |
1988-02-10 |
Beecham Group Plc |
Pharmaceutical preparation
|
|
MC2029A1
(fr)
|
1988-05-16 |
1990-04-25 |
Asta Pharma Ag |
(n-heterocyclyl)-3 diamino-2,6 pyridines substituees et leurs n-oxydes,preparation de ces composes et leur application comme medicaments
|
|
US5629307A
(en)
|
1989-10-20 |
1997-05-13 |
Olney; John W. |
Use of ibogaine in reducing excitotoxic brain damage
|
|
US6004945A
(en)
|
1990-05-10 |
1999-12-21 |
Fukunaga; Atsuo F. |
Use of adenosine compounds to relieve pain
|
|
IN172468B
(https=)
|
1990-07-14 |
1993-08-14 |
Asta Medica Ag |
|
|
US5643921A
(en)
|
1990-09-26 |
1997-07-01 |
E.R. Squibb & Sons, Inc. |
Cardiopulmonary bypass and organ transplant using a potassium channel activator
|
|
US5234947A
(en)
|
1991-11-07 |
1993-08-10 |
New York University |
Potassium channel activating compounds and methods of use thereof
|
|
DE4200259A1
(de)
|
1992-01-08 |
1993-07-15 |
Asta Medica Ag |
Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
|
|
US5262419A
(en)
|
1992-06-11 |
1993-11-16 |
E. R. Squibb & Sons, Inc. |
Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
|
|
CA2115792C
(en)
|
1993-03-05 |
2005-11-01 |
David J. Mayer |
Method for the treatment of pain
|
|
US5428039A
(en)
|
1994-02-20 |
1995-06-27 |
The Center For Innovative Technology |
Method for electively achieving reversible hyperpolarized cardiac arrest
|
|
JP4097285B2
(ja)
|
1994-09-22 |
2008-06-11 |
リチャード・アラン・スミス |
種々の頑固な疾患の治療のための医薬の製造に有用な組成物
|
|
US5679706A
(en)
|
1994-09-30 |
1997-10-21 |
Bristol-Myers Squibb Company |
Combination of a potassium channel activator and an antiarrhythmic agent
|
|
WO1996019233A2
(en)
|
1994-12-12 |
1996-06-27 |
Omeros Medical Systems, Inc. |
Irrigation solution and method for inhibition of pain, inflammation and spasm
|
|
DE19539861A1
(de)
|
1995-10-26 |
1997-04-30 |
Asta Medica Ag |
Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
|
|
DE19701694A1
(de)
|
1997-01-20 |
1998-07-23 |
Asta Medica Ag |
Neue Modifikationen des 2-Amino-4-(4-fluorbenzylamino)-l-ethoxycarbonyl-aminobenzen sowie Verfahren zu ihrer Herstellung
|
|
US5760007A
(en)
|
1997-07-16 |
1998-06-02 |
Ortho Pharmaceutical Corporation |
Anticonvulsant derivatives useful in treating neuropathic pain
|
|
AU8561298A
(en)
|
1997-08-08 |
1999-03-01 |
Chugai Seiyaku Kabushiki Kaisha |
Remedies for complications of diabetes
|
|
US6265417B1
(en)
|
1997-12-18 |
2001-07-24 |
Abbott Laboratories |
Potassium channel openers
|
|
US6593335B1
(en)
|
1997-12-18 |
2003-07-15 |
Abbott Laboratories |
Potassium channel openers
|
|
US6211171B1
(en)
|
1998-05-19 |
2001-04-03 |
Dalhousie University |
Use of antidepressants for local analgesia
|
|
JP3441970B2
(ja)
|
1998-06-30 |
2003-09-02 |
株式会社サミー |
豆腐の製造方法及び製造装置
|
|
BR9916162A
(pt)
|
1998-12-14 |
2001-09-04 |
Cellegy Pharma Inc |
Composição e método para o tratamento de um distúrbio anorretal e para controlar a dor associada com o mesmo
|
|
US6281211B1
(en)
|
1999-02-04 |
2001-08-28 |
Euro-Celtique S.A. |
Substituted semicarbazides and the use thereof
|
|
GB9903476D0
(en)
|
1999-02-17 |
1999-04-07 |
Zeneca Ltd |
Therapeutic agents
|
|
US6451857B1
(en)
|
1999-03-10 |
2002-09-17 |
Warner-Lambert Company |
Analgesic compositions comprising anti-epileptic compounds and methods of using same
|
|
AU766648B2
(en)
|
1999-03-17 |
2003-10-23 |
Axys Pharmaceuticals, Inc. |
Compounds and methods for modulation of estrogen receptors
|
|
AT409083B
(de)
|
1999-04-01 |
2002-05-27 |
Sanochemia Pharmazeutika Ag |
Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
|
|
US6610324B2
(en)
|
1999-04-07 |
2003-08-26 |
The Mclean Hospital Corporation |
Flupirtine in the treatment of fibromyalgia and related conditions
|
|
GB9915414D0
(en)
|
1999-07-01 |
1999-09-01 |
Glaxo Group Ltd |
Medical use
|
|
PT1200073E
(pt)
|
1999-07-06 |
2007-03-30 |
Lilly Co Eli |
Antagonistas selectivos do receptor de iglur5 para o tratamento de enxaqueca
|
|
US6472165B1
(en)
|
1999-08-03 |
2002-10-29 |
Arzneimittelwerk Dresden Gmbh |
Modulatory binding site in potassium channels for screening and finding new active ingredients
|
|
ATE380176T1
(de)
|
1999-08-04 |
2007-12-15 |
Icagen Inc |
Benzanilide als öffner des kaliumkanals
|
|
EP1200086A4
(en)
|
1999-08-04 |
2009-05-27 |
Icagen Inc |
THERAPEUTIC OR PROPHYLACTIC METHODS OF PAIN AND ANXIETY
|
|
US6495550B2
(en)
|
1999-08-04 |
2002-12-17 |
Icagen, Inc. |
Pyridine-substituted benzanilides as potassium ion channel openers
|
|
US6117900A
(en)
|
1999-09-27 |
2000-09-12 |
Asta Medica Aktiengesellschaft |
Use of retigabine for the treatment of neuropathic pain
|
|
US6383511B1
(en)
|
1999-10-25 |
2002-05-07 |
Epicept Corporation |
Local prevention or amelioration of pain from surgically closed wounds
|
|
US6538004B2
(en)
|
2000-03-03 |
2003-03-25 |
Abbott Laboratories |
Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
|
|
US20020015730A1
(en)
|
2000-03-09 |
2002-02-07 |
Torsten Hoffmann |
Pharmaceutical formulations and method for making
|
|
US6348486B1
(en)
|
2000-10-17 |
2002-02-19 |
American Home Products Corporation |
Methods for modulating bladder function
|
|
US6589986B2
(en)
|
2000-12-20 |
2003-07-08 |
Wyeth |
Methods of treating anxiety disorders
|
|
US6469042B1
(en)
|
2001-02-20 |
2002-10-22 |
Bristol-Myers Squibb Company |
Fluoro oxindole derivatives as modulators if KCNQ potassium channels
|
|
US20020183395A1
(en)
|
2001-04-04 |
2002-12-05 |
Wyeth |
Methods for treating hyperactive gastric motility
|
|
GB0119711D0
(en)
|
2001-08-13 |
2001-10-03 |
Unilever Plc |
Process for the production of detergent granules
|
|
GB0121214D0
(en)
|
2001-08-31 |
2001-10-24 |
Btg Int Ltd |
Synthetic method
|
|
WO2003068769A1
(en)
|
2002-02-12 |
2003-08-21 |
Pfizer Inc. |
Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh)
|
|
WO2003097586A1
(en)
|
2002-05-17 |
2003-11-27 |
Janssen Pharmaceutica N.V. |
Aminotetralin-derived urea modulators of vanilloid vr1 receptor
|
|
AUPS312602A0
(en)
|
2002-06-21 |
2002-07-18 |
James Cook University |
Organ arrest, protection, preservation and recovery
|
|
US7419981B2
(en)
|
2002-08-15 |
2008-09-02 |
Pfizer Inc. |
Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
|
|
US7045551B2
(en)
|
2002-11-22 |
2006-05-16 |
Bristol-Myers Squibb Company |
1-aryl-2-hydroxyethyl amides as potassium channel openers
|
|
ATE488231T1
(de)
|
2002-12-23 |
2010-12-15 |
Icagen Inc |
Quinazolinone als kaliumkanalmodulatoren
|
|
ES2282701T3
(es)
|
2002-12-27 |
2007-10-16 |
H. Lundbeck A/S |
Derivados de 1,2,4-triaminobenceno utiles para tratar trastornos del sistema nervioso central.
|
|
EP1606247A1
(en)
|
2003-03-14 |
2005-12-21 |
H. Lundbeck A/S |
Substituted aniline derivatives
|
|
WO2004082677A1
(en)
|
2003-03-21 |
2004-09-30 |
H. Lundbeck A/S |
Substituted p-diaminobenzene derivatives
|
|
MXPA05010174A
(es)
|
2003-04-25 |
2005-11-08 |
Lundbeck & Co As H |
Derivados de indol e indolina sustituidos.
|
|
WO2004105795A1
(en)
|
2003-05-27 |
2004-12-09 |
Altana Pharma Ag |
Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
|
|
US20050070570A1
(en)
|
2003-06-18 |
2005-03-31 |
4Sc Ag |
Novel potassium channels modulators
|
|
JP2007505142A
(ja)
|
2003-09-10 |
2007-03-08 |
セダーズ−シナイ メディカル センター |
血液脳関門を通過する薬剤のカリウムチャネル媒介性送達
|
|
US20050089559A1
(en)
|
2003-10-23 |
2005-04-28 |
Istvan Szelenyi |
Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
|
|
DE10359335A1
(de)
|
2003-10-23 |
2005-05-25 |
Viatris Gmbh & Co. Kg |
Kombinationen aus Kaliumkanalöffnern und Natriumkanalinhibitoren oder Natriumkanal beeinflussenden Wirkstoffen zur Behandlung von Schmerzzuständen
|
|
ES2235626B1
(es)
|
2003-11-10 |
2006-11-01 |
Almirall Prodesfarma, S.A. |
Formas de administracion masticables, no comprimidas dosificadas individualmente.
|
|
US7553858B2
(en)
|
2003-12-17 |
2009-06-30 |
Meda Pharma Gmbh & Co. Kg |
Combination of flupirtine and tramadol
|
|
US8236861B2
(en)
|
2004-02-13 |
2012-08-07 |
Hormos Medical Corporation |
Method for enhancing the bioavailablity of ospemifene
|
|
TWI349666B
(en)
|
2004-03-12 |
2011-10-01 |
Lundbeck & Co As H |
Substituted morpholine and thiomorpholine derivatives
|
|
AU2005233642A1
(en)
|
2004-04-13 |
2005-10-27 |
Astellas Pharma Inc. |
Polycyclic pyridines as potassium ion channel modulators
|
|
RU2006139930A
(ru)
|
2004-05-03 |
2008-06-10 |
Дюк Юниверсити (Сша/Сша) (Us) |
Составы для содействия снижению веса
|
|
UA89503C2
(uk)
|
2004-09-13 |
2010-02-10 |
Х. Луннбек А/С |
Заміщені похідні аніліну
|
|
CA2589001A1
(en)
|
2004-11-19 |
2006-05-26 |
Kissei Pharmaceutical Co., Ltd. |
Preventive or therapeutic agent for neuropathic pain
|
|
EP1688141A1
(en)
|
2005-01-31 |
2006-08-09 |
elbion AG |
The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
|
|
EP1861394A1
(en)
|
2005-03-03 |
2007-12-05 |
H.Lundbeck A/S |
Substituted pyridine derivatives
|
|
US7683058B2
(en)
|
2005-09-09 |
2010-03-23 |
H. Lundbeck A/S |
Substituted pyrimidine derivatives
|
|
WO2007128462A1
(en)
|
2006-05-02 |
2007-11-15 |
Chris Rundfeldt |
Potassium channel activators for the prevention and treatment of dystonia and dystonia-like symptoms
|
|
SG174095A1
(en)
*
|
2006-08-23 |
2011-09-29 |
Valeant Pharmaceuticals Int |
Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
|
|
US8993593B2
(en)
|
2006-08-23 |
2015-03-31 |
Valeant Pharmaceuticals International |
N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
|
|
CN101578259A
(zh)
|
2006-11-28 |
2009-11-11 |
威朗国际制药公司 |
作为钾通道调节剂的1,4-二氨基双环瑞替加滨类似物
|
|
US20090018154A1
(en)
|
2007-05-17 |
2009-01-15 |
Endo Pharmaceuticals, Inc., A Corporation Of Delaware |
Opioid and methods of making and using the same
|
|
AR070513A1
(es)
|
2007-08-01 |
2010-04-14 |
Lundbeck & Co As H |
Uso de abridores de canales de potasio kcnq para reducir los sintomas o tratar desordenes o afecciones en las cuales se encuentra anulado el sis-tema dopaminergico como por ejemplo esquizofrenia y trastorno depresivo mayor
|
|
JP2011506391A
(ja)
|
2007-12-11 |
2011-03-03 |
ノイロサーチ アクティーゼルスカブ |
カリウムチャネル活性化因子として有用な、新規の２−エチル−メチル−アミノ−３−アミド−６−アミノ−ピリジン誘導体
|
|
JP2011507800A
(ja)
|
2007-12-26 |
2011-03-10 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
癲癇、精神障害、または感覚器官の障害のためのａｍｐａ受容体アンタゴニスト
|
|
US20100323016A1
(en)
|
2008-07-18 |
2010-12-23 |
Biljana Nadjsombati |
Modified release formulation and methods of use
|
|
JP2013517315A
(ja)
|
2010-01-20 |
2013-05-16 |
グラクソ グループ リミテッド |
新規組成物
|
|
CA2808501A1
(en)
|
2010-08-23 |
2012-03-01 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical composition of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxy propyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration therof
|
|
JP5248585B2
(ja)
*
|
2010-12-15 |
2013-07-31 |
ゼノン・ファーマシューティカルズ・インコーポレイテッド |
治療薬としてのニコチンアミド誘導体およびそれらの使用
|
|
WO2013067591A1
(en)
|
2011-11-10 |
2013-05-16 |
Relevare Australia Pty Ltd |
Topical formulations for pain management
|
|
US10500216B2
(en)
|
2011-11-18 |
2019-12-10 |
Corcept Therapeutics, Inc. |
Optimizing mifepristone absorption
|
|
SI2819998T1
(sl)
|
2012-03-01 |
2022-07-29 |
Array Biopharma Inc. |
Kristalinske oblike 1-(3-tert-butil-1-P-tolil-1H-pirazol-5-il)-3- (5-fluoro-2-(1-(2-hidroksietil)-1H-indazol-5-iloksi)benzil)urea hidroklorida
|
|
WO2013167999A2
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of neurologic diseases
|
|
US9248122B2
(en)
|
2012-11-28 |
2016-02-02 |
Grünenthal GmbH |
Heteroquinoline-3-carboxamides as KCNQ2/3 modulators
|
|
EP2970188A4
(en)
|
2013-03-15 |
2016-10-19 |
Vm Therapeutics Llc |
NOVEL CRYSTALLINE FORMS
|
|
DK3233786T3
(da)
|
2014-12-16 |
2022-05-09 |
Ptc Therapeutics Inc |
Polymorfe og amorfe former af (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6- dioxocyclohexa-1,4-dienyl)butanamid
|
|
BR112020006796A2
(pt)
|
2017-10-10 |
2020-12-29 |
Khawla Abu-Izza |
Composições de sal de sulfassalazina e métodos de uso das mesmas
|
|
EP4241843B1
(en)
|
2018-02-20 |
2025-05-21 |
H. Lundbeck A/S |
Alcohol derivatives as kv7 potassium channel openers
|
|
WO2019217924A1
(en)
|
2018-05-11 |
2019-11-14 |
Xenon Pharmaceuticals Inc. |
Methods for enhancing the bioavailability and exposure of a voltage-gated potassium channel opener
|
|
TWI886158B
(zh)
*
|
2019-10-10 |
2025-06-11 |
加拿大商再諾製藥公司 |
選擇性鉀通道調節劑之固態晶型
|
|
CA3151863C
(en)
|
2021-10-27 |
2024-01-02 |
Shanghai Zhimeng Biopharma, Inc. |
Compound as potassium channel regulator and preparation and use thereof
|